Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO BRIT J HAEMATOL
Randomized phase II study of weekly carfilzomib 70 mg/m(2) and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients Haematologica
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms bioRxiv
Low input capture Hi-C (liCHi-C) identifies promoter-enhancer interactions at high-resolution Nat Commun
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis HEMASPHERE
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors FRONT IMMUNOL
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion CANCER GENE THER
Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects INT J MOL SCI
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome Blood Adv